{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T01:19:51Z","timestamp":1776388791172,"version":"3.51.2"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Vascular Surgery"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1053\/j.semvascsurg.2025.01.009","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T16:16:57Z","timestamp":1737994617000},"page":"85-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diabetic foot infections: Questions for an infectious disease consultant"],"prefix":"10.1053","volume":"38","author":[{"given":"Varidhi","family":"Nauriyal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Byers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0001","unstructured":"National diabetes statistics report. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html, Accessed 10\/10\/2024."},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0002","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/07853890.2016.1231932","article-title":"Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis","volume":"49","author":"Zhang","year":"2017","journal-title":"Ann Med"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0003","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2337\/dci22-0043","article-title":"Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers","volume":"46","author":"McDermott","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0004","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/dme.13537","article-title":"Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study","volume":"35","author":"Ndosi","year":"2018","journal-title":"Diabet Med"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0005","first-page":"286","article-title":"IWGDF\/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF\/IDSA 2023)","volume":"79","author":"Senneville","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0006","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/511036","article-title":"Validation of the Infectious Diseases Society of America's diabetic foot infection classification system","volume":"44","author":"Lavery","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0007","article-title":"The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI)","volume":"59","author":"Sr","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0008","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ejvs.2019.03.040","article-title":"The prognostic value of the WIfI classification in patients with chronic limb threatening ischaemia: a systematic review and meta-analysis","volume":"58","author":"van Reijen","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2023.10578","article-title":"Diabetic foot ulcers: a review","volume":"330","author":"Armstrong","year":"2023","journal-title":"JAMA"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0010","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/cid\/ciw445","article-title":"Diagnostic accuracy of probe to bone to detect osteomyelitis in the diabetic foot: a systematic review","volume":"63","author":"Lam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23610","article-title":"Imaging tests for the detection of osteomyelitis: a systematic review","volume":"23","author":"Llewellyn","year":"2019","journal-title":"Health Technol Assess"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0012","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2022.055","article-title":"The role of serial radiographs in diagnosing diabetic foot bone osteomyelitis","volume":"14","author":"Leone","year":"2022","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0013","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1464-5491.2010.03150.x","article-title":"Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients?","volume":"28","author":"Arag\u00f3n-S\u00e1nchez","year":"2011","journal-title":"Diabet Med"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0014","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/clind\/24.4.643","article-title":"Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens","volume":"24","author":"Lipsky","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1053\/j.semvascsurg.2025.01.009_bib0015","doi-asserted-by":"crossref","first-page":"e3250","DOI":"10.1002\/dmrr.3250","article-title":"Diagnosing diabetic foot osteomyelitis","volume":"36","author":"Senneville","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0016","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/498112","article-title":"Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures","volume":"42","author":"Senneville","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0017","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/dmrr.2425","article-title":"Deep wound cultures correlate well with bone biopsy culture in diabetic foot osteomyelitis","volume":"29","author":"Malone","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0018","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s10096-019-03547-6","article-title":"Comparison of microbiological results obtained from per-wound bone biopsies versus transcutaneous bone biopsies in diabetic foot osteomyelitis: a prospective cohort study","volume":"38","author":"Couturier","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0019","doi-asserted-by":"crossref","first-page":"ofaa393","DOI":"10.1093\/ofid\/ofaa393","article-title":"Percutaneous bone biopsy for diabetic foot osteomyelitis: a systematic review and meta-analysis","volume":"7","author":"Schechter","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0020","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/j.jfas.2011.08.005","article-title":"Statistical reliability of bone biopsy for the diagnosis of diabetic foot osteomyelitis","volume":"50","author":"Meyr","year":"2011","journal-title":"J Foot Ankle Surg"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0021","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1186\/s13063-021-05472-6","article-title":"Using a BonE BiOPsy (BeBoP) to determine the causative agent in persons with diabetes and foot osteomyelitis: study protocol for a multicentre, randomised controlled trial","volume":"22","author":"Gramberg","year":"2021","journal-title":"Trials"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.11321","article-title":"Use of novel strategies to develop guidelines for management of pyogenic osteomyelitis in adults: a WikiGuidelines Group Consensus Statement","volume":"5","author":"Spellberg","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0023","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/dc13-1526","article-title":"Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial","volume":"37","author":"L\u00e1zaro-Mart\u00ednez","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0024","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2337\/dc14-1514","article-title":"Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study","volume":"38","author":"Tone","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0025","doi-asserted-by":"crossref","first-page":"e1539","DOI":"10.1093\/cid\/ciaa1758","article-title":"Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: a prospective, randomized, non-inferiority pilot trial","volume":"73","author":"Gariani","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0026","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1093\/cid\/cis346","article-title":"Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0027","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16003","article-title":"Adjunctive rifampin therapy for diabetic foot osteomyelitis in the Veterans Health Administration","volume":"2","author":"Wilson","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0029","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/380449","article-title":"Linezolid diabetic foot infections study group, treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam\/amoxicillin-clavulanate","volume":"38","author":"Lipsky","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0002-9343(87)90894-1","article-title":"Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy","volume":"83","author":"Bamberger","year":"1987","journal-title":"Am J Med"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0031","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1053\/j.jfas.2006.04.002","article-title":"The role of early surgical debridement and revascularization in patients with diabetes and deep foot space abscess: retrospective review of 106 patients with diabetes","volume":"45","author":"Faglia","year":"2006","journal-title":"J Foot Ankle Surg"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0032","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jcot.2020.12.014","article-title":"Conservative surgery for chronic diabetic foot osteomyelitis: procedures and recommendations","volume":"16","author":"L\u00e1zaro-Mart\u00ednez","year":"2020","journal-title":"J Clin Orthop Trauma"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0033","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00125-006-0491-1","article-title":"High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study","volume":"50","author":"Prompers","year":"2007","journal-title":"Diabetologia"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0034","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00125-008-0940-0","article-title":"Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study","volume":"51","author":"Prompers","year":"2008","journal-title":"Diabetologia"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0035","doi-asserted-by":"crossref","first-page":"e3686","DOI":"10.1002\/dmrr.3686","article-title":"The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer","volume":"40","author":"Fitridge","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0036","unstructured":"FDA approves Dalvance to treat skin infections [press release]. US Food and Drug Administration. May 23, 2014. https:\/\/web.archive.org\/web\/20140525203517\/http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm398724.htm, Accessed 2\/16\/2024."},{"key":"10.1053\/j.semvascsurg.2025.01.009_bib0037","doi-asserted-by":"crossref","first-page":"ofy331","DOI":"10.1093\/ofid\/ofy331","article-title":"Dalbavancin for the treatment of osteomyelitis in adult patients: a randomized clinical trial of efficacy and safety","volume":"6","author":"Rappo","year":"2019","journal-title":"Open Forum Infect Dis"}],"container-title":["Seminars in Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895796725000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895796725000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T23:34:48Z","timestamp":1745364888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895796725000110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0895796725000110"],"URL":"https:\/\/doi.org\/10.1053\/j.semvascsurg.2025.01.009","relation":{},"ISSN":["0895-7967"],"issn-type":[{"value":"0895-7967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic foot infections: Questions for an infectious disease consultant","name":"articletitle","label":"Article Title"},{"value":"Seminars in Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semvascsurg.2025.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}